Cargando…
Meningioma classification by immunohistochemistry: A replicability study
INTRODUCTION: Meningiomas account for nearly 40% of intracranial tumors. Recently, the immunohistochemistry (IHC) markers S100B, SCGN, ACADL and MCM2 have been shown to be associated with underlying biological subtypes of meningioma (MG1-MG4). We aimed to evaluate these IHC markers in a clinical set...
Autores principales: | Näslund, Olivia, Lipatnikova, Anna, Dénes, Anna, Lindskog, Cecilia, Bontell, Thomas Olsson, Smits, Anja, Jakola, Asgeir S., Corell, Alba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845417/ https://www.ncbi.nlm.nih.gov/pubmed/36685704 http://dx.doi.org/10.1016/j.bas.2022.101711 |
Ejemplares similares
-
DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2021) -
The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas
por: Dénes, Anna, et al.
Publicado: (2023) -
Stemness and clinical features in relation to the subventricular zone in diffuse lower-grade glioma: an exploratory study
por: Corell, Alba, et al.
Publicado: (2022) -
Indications and outcome in surgically treated asymptomatic meningiomas: a single-center case-control study
por: Näslund, Olivia, et al.
Publicado: (2020) -
WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)